PRAD and BPH samples were analyzed by nucleic acid extraction and PCR, and the expression levels of key molecules in PANoptosis, including ZBP1, RIPK1, CASP6, CASP1, CASP8, and FADD, were identified. This evidence concerns the gene RIPK1 and benign prostatic hyperplasia.